B

BERRUTI A.

Last name: BERRUTI A.

2022 (v1)

Publication

Metadata-only

The diagnostic and prognostic role of combined [18F]FDG and [68Ga]-DOTA-peptides PET/CT in primary pulmonary carcinoids: a multicentric experience

Albano D. Dondi F. Bauckneht M.

Objectives: In the present retrospective multicentric study, we combined [68Ga]-DOTA-peptides and [18F]FDG-PET/CT findings aiming to investigate their capability to differentiate typical (TC) and atypical pulmonary carcinoids (AC) and their prognostic role. Methods: From three centers, 61 patients were retrospectively included. Based on a dual...

Uploaded on: February 7, 2024
2021 (v1)

Publication

Metadata-only

The prognostic power of 18F-FDG PET/CT extends to estimating systemic treatment response duration in metastatic castration-resistant prostate cancer (mCRPC) patients

Bauckneht M. Bertagna F. Donegani M. I.

Background: We aimed to test whether the prognostic value of 18 F‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) in metastatic castration-resistant prostate cancer (mCRPC) extends to the estimation of systemic treatment response duration. Methods: mCRPC patients submitted to FDG-PET/CT in four Italian centers...

Uploaded on: February 7, 2024
2016 (v1)

Publication

Metadata-only

Corrigendum to "Gene expression profiling in breast cancer: A clinical perspective" [The Breast 22 (2013) 109-120 [doi:10.1016/j.breast.2013.01.016.]]

Arpino G. Generali D. Sapino A.

No description

Uploaded on: May 12, 2023